VEGFRs
Showing 1 - 21 of 21
Breast Cancer Trial in Guangzhou (Fulvestrant plus Anlotinib)
Recruiting
- Breast Cancer
- Fulvestrant plus Anlotinib
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 16, 2021
Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)
Not yet recruiting
- Metastatic Colorectal Carcinoma
- Pentoxifylline
- +3 more
- (no location specified)
Nov 1, 2023
Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)
Recruiting
- Melanoma Stage III
-
North Sydney, New South Wales, AustraliaMelanoma Institute Australia
Oct 26, 2022
Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- +4 more
- Biospecimen Collection
- +5 more
- (no location specified)
Jan 14, 2023
Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)
Completed
- Hormone Refractory Prostate Cancer
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Recurrent Glioblastoma Trial in Philadelphia (biological, drug, radiation)
Terminated
- Recurrent Glioblastoma
- [18F]fluoromisonidazole
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 13, 2020
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy
Unknown status
- Glioblastoma
-
Fuzhou, Fujian, ChinaFuzhou General Hospital
Feb 29, 2020
Glioblastoma Trial in Guangzhou (anlotinib combined with dose-dense temozolomide)
Recruiting
- Glioblastoma
- anlotinib combined with dose-dense temozolomide
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 11, 2020
Lung Cancer, Nonsmall Cell Trial in Guangzhou (Gefitinib, Anlotinib Hydrochloride, Placebo)
Unknown status
- Lung Cancer, Nonsmall Cell
- Gefitinib
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center of Sun Yat-Sen University (CCSU)
Nov 7, 2019
Age-Related Macular Degeneration Trial in Brussels (Genotype analysis)
Completed
- Age-Related Macular Degeneration
- Genotype analysis
-
Brussels, BelgiumCHU Brugmann
Jan 18, 2018
Small Cell Lung Cancer, Small Cell Lung Cancer Recurrent Trial in Goyang-si (BIBF 1120)
Completed
- Small Cell Lung Cancer
- Small Cell Lung Cancer Recurrent
- BIBF 1120
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Aug 24, 2017
Renal Cell Carcinoma, Kidney Cancer Trial in Italy (Sunitinib, Isoquercetin, Placebo)
Unknown status
- Renal Cell Carcinoma
- Kidney Cancer
- Sunitinib
- +2 more
-
Rionero in vulture, Potenza, Italy
- +4 more
Jan 16, 2017
Non Small Cell Lung Cancer, Brain Metastasis Trial in Wuhan (bevacizumab, standard chemo and radiation)
Unknown status
- Non Small Cell Lung Cancer
- Brain Metastasis
- bevacizumab, standard chemotherapy and radiation
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Jul 2, 2013